🔥🐔 BizChicken 🐔🔥
Companies Similar to SpringWorks Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Catalyst Pharmaceuticals, Inc.
Firdapse
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare neuromuscular and neurological diseases in the United States, including products like Firdapse and Ruzurgi for Lambert-Eaton Myasthenic Syndrome.
Symbol: CPRX
Recent Price: $21.07
Industry: Biotechnology
CEO: Mr. Richard John Daly M.B.A.
Sector: Healthcare
Employees: 167
Address: 355 Alhambra Circle, Coral Gables, FL 33134
Phone: 305 420 3200
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Scholar Rock Holding Corporation
Apitegromab
Scholar Rock Holding Corporation is a biopharmaceutical company focused on developing medicines for serious diseases where protein growth factor signaling plays a critical role. The company advances Apitegromab, targeting spinal muscular atrophy, and SRK-181 for cancer treatments, alongside a pipeline addressing neuromuscular disorders, cancer, and fibrosis.
About | About | About | News | Events | ESG | About | About | About | Careers | About | About | Leadership | Directors | About | Contact | Contact | Careers
Symbol: SRRK
Recent Price: $42.91
Industry: Biotechnology
CEO: Dr. Jay Thomas Backstrom M.D., M.P.H.
Sector: Healthcare
Employees: 150
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 857 259 3860
Leadership
- David Hallal, Chairman of the Scholar Rock Board and Chief Executive Officer of ElevateBio
- Srini Akkaraju, MD, PhD, Founder & Managing Partner, Samsara BioCapital
- Jay Backstrom, M.D., MPH, President & CEO
- Richard Brudnick, Chief Business Officer, Prime Medicine
- Kristina Burow, Managing Director, ARCH Venture Partners
- Jeffrey Flier, MD, Higginson Professor of Physiology and Medicine and Harvard University Distinguished Service Professor; Former Dean of Harvard Medical School
- Michael Gilman, PhD, CEO, Arrakis Therapeutics
- Katie Peng, Chief Commercial Officer, Denali Therapeutics
- Joshua Reed, Chief Financial Officer of Omega Therapeutics
- Akshay Vaishnaw, MD, PhD, Chief Innovation Officer, Alnylam Pharmaceuticals
Last updated: 2024-12-31
Sarepta Therapeutics, Inc.
EXONDYS 51, VYONDYS 53, AMONDYS 45, SRP-5051, SRP-9001, SRP-9003
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on developing RNA-targeted therapeutics and gene therapies for rare diseases, including treatments for Duchenne muscular dystrophy.
Contact | About | Leadership | About | About | About | Locations | About | About | About | About
Symbol: SRPT
Recent Price: $121.19
Industry: Biotechnology
CEO: Mr. Douglas S. Ingram Esq.
Sector: Healthcare
Employees: 1314
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 274 4000
Leadership
- Douglas S. Ingram, President and Chief Executive Officer
- Bilal Arif, Executive Vice President, Chief Technical Operations Officer
- Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer
- Ryan E. Brown, JD, Executive Vice President, Chief General Counsel
- Ian M. Estepan, Executive Vice President, Chief Financial Officer
- Dallan Murray, Executive Vice President, Chief Customer Officer
- Alison Nasisi, Executive Vice President, Chief People Officer
- Louise R. Rodino-Klapac, PhD, Executive Vice President, Head of R&D, Chief Scientific Officer
- Will Tilton, Senior Vice President, Head of Strategy, Chief of Staff
- M. Kathleen Behrens, PhD, Chairwoman
- Richard J. Barry,
- Kathryn Boor, PhD,
- Michael Chambers,
- Deirdre Connelly,
- Stephen L. Mayo, PhD,
- Claude Nicaise, MD,
- Hans Wigzell, MD, PhD,
- John C. Martin, PhD (In Memoriam),
- Annemieke Aartsma-Rus, PhD,
- Carsten Bönnemann, MD,
- Joy Cavagnaro, PhD, DABT, Fellow ATS,
- Kay Davies, PhD, DBE FMedSci FRS,
- Steven Gray, PhD,
- Angela J. Russell, DPhil,
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
BeyondSpring Inc.
Plinabulin
Beyond Spring Inc. is a clinical stage biopharmaceutical company focused on developing cancer therapies, including its lead asset Plinabulin, which is in advanced clinical trials.
Contact | Careers | Careers | About | Leadership | About | Directors | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: BYSI
Recent Price: $1.62
Industry: Biotechnology
CEO: Dr. Lan Huang Ph.D.
Sector: Healthcare
Employees: 36
Address: 28 Liberty Street, New York, NY 10005
Phone: 646 305 6387
Last updated: 2024-12-31
Cyclacel Pharmaceuticals, Inc.
Fadraciclib, CYC140, Sapacitabine, Seliciclib
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.
Symbol: CYCC
Recent Price: $0.37
Industry: Biotechnology
CEO: Mr. Spiro George Rombotis
Sector: Healthcare
Employees: 12
Address: 200 Connell Drive, Berkeley Heights, NJ 07922
Phone: 908 517 7330
Last updated: 2024-12-31
Edgewise Therapeutics, Inc.
EDG-5506
Edgewise Therapeutics, Inc. is a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, including treatments for Duchenne muscular dystrophy and Becker muscular dystrophy.
About | Leadership | Contact | Contact | Careers | About | About | About | About | About | About
Symbol: EWTX
Recent Price: $27.05
Industry: Biotechnology
CEO: Dr. Kevin Koch Ph.D.
Sector: Healthcare
Employees: 97
Address: 3415 Colorado Avenue, Boulder, CO 80303
Phone: 303 735 8373
Leadership
- Kevin Koch, Ph.D., Director
- Alan Russell, Ph.D., Director and Co-Founder
- R. Michael Carruthers, Chief Financial Officer
- Behrad Derakhshan, Ph.D., Chief Business Officer
- Joanne M. Donovan, M.D., Ph.D., Chief Medical Officer
- John Moore, General Counsel
- Marc Semigran, M.D., Chief Development Officer
- Peter Thompson, M.D., Chairman and Co-Founder
- Laura Brege, Director
- Badreddin Edris, Ph.D., Director and Co-Founder
- Jonathan C. Fox, M.D., Ph.D., FACC, Director
- Arlene Morris, Director
- Jon Root, M.D., Director
Last updated: 2024-12-31
FibroGen, Inc.
Roxadustat, Pamrevlumab
Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.
Symbol: FGEN
Recent Price: $0.53
Industry: Biotechnology
CEO: Mr. Thane Wettig
Sector: Healthcare
Employees: 486
Address: 409 Illinois Street, San Francisco, CA 94158
Phone: 415 978 1200
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
SpringWorks Therapeutics, Inc.
nirogacestat
SpringWorks Therapeutics acquires, develops, and commercializes medicines for underserved patient populations with rare diseases and cancer, focusing on products like nirogacestat for desmoid tumors and mirdametinib for neurofibromatosis.
Contact | Contact | Contact | Careers | Careers | Benefits | Careers | News | Events | ESG | About | About | About | About | Contact | About | About | Contact | About | About | About | About | About | About | About | About | Contact | About
Symbol: SWTX
Recent Price: $36.34
Industry: Biotechnology
CEO: Mr. Saqib Islam J.D.
Sector: Healthcare
Employees: 305
Address: 100 Washington Boulevard, Stamford, CT 06902
Phone: 203 883 9490
Last updated: 2024-12-31
Syros Pharmaceuticals, Inc.
Tamibarotene
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.
About | Leadership | Directors | About | Contact | Careers | Vision/Values | DEI | Careers | About | About
Symbol: SYRS
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Conley Chee
Sector: Healthcare
Employees: 68
Address: 35 CambridgePark Drive, Cambridge, MA 02140
Phone: 617 744 1340
Leadership
- Conley Chee, President and Chief Executive Officer
- Jason Haas, Chief Financial Officer
- Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
- Lisa Roberts, VP Human Resources
- David A. Roth, M.D., Chief Medical Officer
- Kristin Stephens, Chief Development Officer
Last updated: 2024-12-31
Verastem, Inc.
VS-6766
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.
Symbol: VSTM
Recent Price: $3.67
Industry: Biotechnology
CEO: Mr. Daniel W. Paterson
Sector: Healthcare
Employees: 73
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 781 292 4200
Last updated: 2024-12-31
Ionis Pharmaceuticals, Inc.
RNA-targeted therapeutics
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States, offering treatments like SPINRAZA, TEGSEDI, and WAYLIVRA, while developing medicines in phase 3 studies for various indications including TTR amyloidosis, severe hypertriglyceridemia, and amyotrophic lateral sclerosis.
About | About | About | DEI | DEI | DEI | DEI | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | About | About | News | About | About | ESG | DEI | DEI | About | About | About | Management | About | About | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | ESG | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | Jobs | About | About
Symbol: IONS
Recent Price: $34.92
Industry: Biotechnology
CEO: Dr. Brett P. Monia Ph.D.
Sector: Healthcare
Employees: 927
Address: 2855 Gazelle Court, Carlsbad, CA 92010
Phone: 760 931 9200
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31